Table 2 Summary of efficacy endpoints in current study
N | No-Tx Ctrl | Pre-Tx Ctrl | Tx | P value |
|---|---|---|---|---|
20 | 117 | 117 | – | |
Mean duration of outbreaks (days) | 6.70 | 8.77 | 2.87 | P < 0.001 (No-Tx Ctrl) |
P < 0.0001 (Pre-Tx Ctrl) | ||||
Median duration of outbreaks (days) | 5.00 | 7.00 | 2.00 | – |
On a scale of 1–7a | 3.95 | 3.35 | 5.82 | P < 0.0001 (both controls) |